Bona Obtains Korean Patent for Child Resistant Nasal Pumps
2021-01-26 By hqt
2021-01-26 By hqt
Bona received the patent certificate from the Korean Intellectual Property office on January 24, 2017.
After obtaining the Chinese patent for a new design of child resistant nasal pumps, Bona received the patent certificate from the Korean Intellectual Property office on January 24, 2017.
Key features of the new child-resistant nasal pump:
Neck: 18mm Screw-on
Closure: Locking neck and locking dust cover. Can't be primed by children.
Dosage: 50mcl to 220mcl with +/-10% tolerance.
Usage: Liquid medicine for the nose.
Fit for: 15ml and 30ml plastic bottle with the screw-on the neck. Customize bottle welcome.
Material: Comply with EUP, EU 10/2011, FDA and USP.
Tested by CPSC approved Lab according to Code of Federal Regulations (CFR) Title 16, Part 1700.20.
Comply with Quality system ISO15378:2011 which special for primary package manufacturing.
Bona's mission is to provide the pharmaceutical industry with innovative, distinctive products, quality services, thereby contributing to the improvement of human health worldwide.